We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products. Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
Breaking the vicious circle of snakebites in the developing world
BTG Specialty Pharmaceuticals supports Asclepius Snakebite Foundation clinic in Guinea
Covid-19 disrupted 97% of supply chains - but ours remained intact
We’re proud to have kept production running, protected our employees, and continued to deliver our products to those who need it.
How a new, online clinical support tool is helping cancer patients
Data science and a free, web-based tool are making it easier to monitor and predict delayed methotrexate clearance.